![[ Previous Article ]](prev.gif){kind=small}
![[ Table of Contents ]](foot.gif){kind=small}
![[ Next Article ]](next.gif){kind=small}
The National Foundation for Infectious Diseases would like to thank those organizations, corporations, and institutions responsible for restricted and unrestricted gifts for the calendar year 1996.
|
Abbott Laboratories Diagnostics Division Alliance Meeting Planners Alza Corporation American Council of Life Insurance American Medical Association American Social Health-System Pharmacists Amgen Inc. Ashland Foundation Astra USA Bayer Corporation Pharmaceutical Division Becton Dickinson & Company Bioject, Inc. Biotechnology Industry Organization Bond Wholesale Pharmaceuticals and Medical Supply Bristol-Myers Squibb Company CHC Software, Inc. Centers for Disease Control and Prevention Centocor, Inc. Channing L. Bete Co., Inc. Cooney/Waters Group Creamer Dickson Basford Decision Systems Eli Lilly and Company Ernst & Young LLP Facts & Comparisons Thomas Ferguson Associates, Inc. Genetics Institute, Inc. Glaxo Wellcome Inc. |
Hepatitis Foundation International Hoechst Marion Roussel, Inc. Hoffmann-LaRoche Inc. Hogan & Hartson, LLP JK Corporation Janssen Pharmaceutica, Inc. Johnson & Johnson Medical, Inc. Kimberly-Clark Professional Health Care Management of Info-Tech, Inc. Merck & Co., Inc. Merck Vaccine Division Mitchell & McCormick, Inc. National Association of Retail Druggists National Infusion Services North American Vaccine, Inc. Ortho-McNeil Pharmaceutical Parke-Davis Pasteur MÇrieux Connaught Pfizer Inc. Pharmacia & Upjohn, Inc. Postgraduate Institute for Medicine The Procter & Gamble Company Public Health Software Systems Rhone-Poulenc Rorer Inc. SCP Communications, Inc. St. Luke's Episcopal Hospital Salick Health Care, Inc. Schering-Plough Corporation Schering-Plough Research Institute |
Science & Health Communications Group Searle Serono Laboratories, Inc. SmithKline Beecham Sullivan Bruyette Teletask, Inc. Tufts Associated Health Plans Warner-Lambert Company Warner-Lambert Pharmaceutical Research Institute Wyeth-Ayerst Laboratories Wyeth-Lederle Vaccines and Pediatrics Zeneca Pharmaceuticals
MEMORIAL FUNDS
Arthur Ashe Fund |
Infectious diseases are the most common cause of death and illness in the world today. In the United States, infectious diseases are now the third most common cause of death. Influenza and pneumonia can affect millions of Americans and kill 40,000 each year. Hospital-acquired infections strike 2 million patients annually causing 20,000 deaths. Antimicrobial resistance threatens to make life-saving antibiotics ineffective.
The National Foundation for Infectious Diseases (NFID) is a nonprofit organization dedicated to public and professional education and research on infectious diseases. The NFID needs your support. Your tax-free dollars will be used in the fight against deadly and crippling diseases. Give generously to help protect the health of yourself and your loved ones.
Name:_______________________________________ Check Enclosed:
$1000
Address:____________________________________ $ 500
$ 100
____________________________________ $ 50
$ 25
City, State, Zip:___________________________ Other $________
Memorials:
This gift is in memory of _________________________________________
Please send acknowledgment to:_____________________________________
The National Foundation for Infectious Diseases (NFID) is proud to announce the availability of two conference and one symposium proceedings.
Coccidioidomycosis contains the Proceedings of the Fifth International Conference on Coccidioidomycosis held in San Diego. The book will be casebound in handsome blue lexotone with gold lettering. The new volume will contain over 500 pages, and will be a companion to the proceedings of the fourth conference held in 1984.
Proceedings of the 5th Symposium on Topics in Mycology: Host-Fungus Interplay, held in Palo Alto, California in 1995, will also be available this fall. As with the Coccidioidomycosis proceedings, this volume will be heavily illustrated and will contain over 500 pages, including a subject index.
Both conference proceedings will sell for $40 per copy, which includes postage and handling. Supplies of these proceedings are limited. Reserve your copies now by sending your check with order form to NFID.
Proceedings from the symposium, HIV Protease Inhibitors: When and How They Should Be Used, have been published as a supplement to the journal, Infections in Medicine. Topics presented at the symposium included an historical perspective and basic science of HIV protease inhibitors; pharmacokinetics and pharmacodynamics of HIV protease inhibitors; overview of resistance and cross-resistance to HIV protease inhibitors; evaluation of plasma r-RNA as a surrogate marker in the treatment of HIV infection; safety profile of HIV protease inhibitors; and a clinician's practice perspectives on the use of HIV protease inhibitors.
Complimentary copies of the symposium proceedings are being provided as a public and professional service by NFID through an unrestricted educational grant from Merck and Co.
NFID Proceedings Order Form
Please send the following:
___ Copies of Coccidioidomycosis
@ $40 per copy = $______
___ Copies of Host-Fungus Interplay
@ $40 per copy = $______
___ Complimentary copy of HIV Protease Inhibitors Proceedings
(check here for one copy)
Total $______
Make check payable to
National Foundation for
Infectious Diseases
4733 Bethesda Avenue, Suite 750
Bethesda, Maryland 20814-5228
________________________________________
Name
________________________________________
Street Address
________________________________________
________________________________________
City, State, Zip